Metrika članka

  • citati u SCindeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u poslednjih 30 dana:19
  • preuzimanja u poslednjih 30 dana:16
članak: 2 od 16  
Back povratak na rezultate
Medicinski časopis
2017, vol. 51, br. 1, str. 15-21
jezik rada: srpski
vrsta rada: stručni članak
doi:10.5937/mckg51-13019


Izolati multirezistentnih bakterija u Univerzitetskom kliničkom centru Republike Srpske
Medicinski fakultet Univerziteta u Banjoj Luci, Banja Luka, Republika Srpska, Bosna i Hercegovina

e-adresa: darijaknez@yahoo.com

Sažetak

Cilj. Cilj ove studije bio je da se utvrdi multirezistencija najčešćih bakterijskih izolata na hirurškoj, internoj i ginekološkoj klinici i Jedinici za intenzivnu medicinsku negu (JIM) Univerzitetskog kliničkog centra (UKC) Republike Srpske od januara do decembra 2015. godine. Metode. Za pribavljanje relevantnih podataka o bakterijskim izolatima i rezistenciji korišćena je retrogradna analiza laboratorijske dokumentacije za navedeni period. Statistička analiza je obavljena uz upotrebu programskog paketa SPSS, uz nivo značajnosti razlike od 5% (α=0.05). Rezultati. Postojala je visoko statistički značajna razlika pojave rezistencije izolovanih bakterija na više grupa antibiotika između različitih vrsta bakterija i bolničkih odeljenja (p<0,001). U ukupnom uzorku multirezistentnih izolata (678) najčešća izolovana bakterija bila je Acinetobacter spp. (46,8%), a po učestalosti su sledili Pseudomonas spp. (16,4%), Klebsiella/Enterobacter spp. (14,2%), Escherichia coli (5,6%), Enterococcus spp. (4,9%), Staphylococcus aureus (4,4%), S. epidermidis (3,1%) i Serratia marcescens (1%). Najveći broj multirezistentnih bakterija izolovan je iz JIM (p<0,001). Zaključak. U ovoj studiji zabeležena je visoka učestalost multirezistentnog Acinetobacter spp. Izolati bakterija iz JIM bili su rezistentniji od izolata sa hirurške, interne i ginekološke klinike.

Ključne reči

Reference

Brkić, D.V., Stanko, A.P., Pleško, S., Tripković, V., Bedenić, B. (2015) Acinetobacter baumannii microbiological and phenotypic characteristics of isolates from Intensive Care Unit of the Department of Internal Medicine at the University Hospital Centre in Zagreb over a four-year period. Signa Vitae - A Journal In Intensive Care and Emergency Medicine, 10(Suppl 1): 13-15
Division of Public Health Services (2015) Recommendations for the prevention & control of MDRO and CDI for healthcare agencies and community settings. February. Dostupno na: http://www.dhhs.nh.gov/dphs/cdcs/hai/documents/mdro.pdf (12.10.2016)
European Centre for Disease Prevention and Control Summary of the latest data on antibiotic resistance in the European Union. Dostupno na: http://ecdc.europa.eu/en/eaad/antibiotics-get-informed/antibiotics-resistance-consumption/Documents/antibiotics-EARS-Net-summary-2016.pdf (1. 3. 2017.)
European Centre for Disease Prevention and Control Carbapenem-resistant acinetobacter baumannii in healthcare settings. Dostupno na: http://ecdc.europa.eu/en/publications/Publications/8-Dec-2016-RRA-Acinetobacter%20baumannii-Europe.pdf (1. 3. 2017.)
Ghafur, A. (2014) Emergence of Pan-drug resistance amongst gram negative bacteria! The First case series from India. Journal of Microbiology and Infectious Diseases, 4(3): 86-91
Huttner, A., Harbarth, S., Carlet, J., Cosgrove, S., Goossens, H., Holmes, A., Jarlier, V., Voss, A., Pittet, D. (2013) Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum. Antimicrobial Resistance and Infection Control, 2(1): 31
Karageorgopoulos, D.E., Falagas, M.E. (2008) Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infectious Diseases, 8(12): 751-762
Khalili, H., Izadpanah, M. (2015) Antibiotic regimens for treatment of infections due to multidrug-resistant Gram-negative pathogens: An evidence-based literature review. Journal of Research in Pharmacy Practice, 4(3): 105
Lee, C., Cho, I., Jeong, B., Lee, S. (2013) Strategies to Minimize Antibiotic Resistance. International Journal of Environmental Research and Public Health, 10(9): 4274-4305
Lisboa, T., Nagel, F. (2011) Infecção por patógenos multi-resistentes na UTI: como escapar?. Revista Brasileira de Terapia Intensiva, 23(2): 120-124
Magiorakos, A.-P., Srinivasan, A., Carey, R.B., Carmeli, Y., Falagas, M.E., Giske, C.G., Harbarth, S., Hindler, J.F., Kahlmeter, G., Olsson-Liljequist, B., Paterson, D.L., Rice, L.B., Stelling, J., Struelens, M.J., Vatopoulos, A., Weber, J.T., Monnet, D. (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology and Infection, 18(3): 268-281
Maragakis, L.L., Perl, T.M. (2008) Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clinical infectious diseases, 46(8): 1254-63
Maraki, S., Mantadakis, E., Mavromanolaki, V.E., Kofteridis, D.P., Samonis, G. (2016) A 5-year Surveillance Study on Antimicrobial Resistance of Acinetobacter baumannii Clinical Isolates from a Tertiary Greek Hospital. Infection & Chemotherapy, 48(3): 190
Mitchell, B.G., Hall, L., MacBeth, D., Gardner, A., Halton, K. (2015) Hospital infection control units: Staffing, costs, and priorities. American Journal of Infection Control, 43(6): 612-616
Munoz-Price, L. S., Fajardo-Aquino, Y., Arheart, K.L., Cleary, T., DePascale, D., Pizano, L., Namias, N., Rivera, J.I., O’Hara, J.A., Doi, Y. (2013) Aerosolization of Acinetobacter baumannii in a Trauma ICU*. Critical Care Medicine, 41(8): 1915-1918
Nathan, C., Cars, O. (2014) Antibiotic Resistance - Problems, Progress, and Prospects. New England Journal of Medicine, 371(19): 1761-1763
Oliveira, V.D.C., Rubio, F.G., Almeida, M.T.G., Nogueira, M.C.L., Pignatari, A.C.C. (2015) Trends of 9,416 multidrug-resistant Gram-negative bacteria. Revista da Associação Médica Brasileira, 61(3): 244-249
Strausbaugh, L.J., Siegel, J.D., Weinstein, R.A. (2006) Preventing transmission of multidrug-resistant bacteria in health care settings: a tale of 2 guidelines. Clinical infectious diseases, 42(6): 828-35
Tsioutis, C., Kritsotakis, E. I., Maraki, S., Gikas, A. (2010) Infections by pandrug-resistant gram-negative bacteria: clinical profile, therapeutic management, and outcome in a series of 21 patients. European Journal of Clinical Microbiology & Infectious Diseases, 29(3): 301-305
U.S. Department of Health and Human Services-Centers for Disease Control and Prevention (2013) Antibiotic resistance threats in the United States. Dostupno na: https://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf (1.3. 2017)
Zilberberg, M.D., Shorr, A.F., Micek, S.T., Vazquez-Guillamet, C., Kollef, M.H. (2014) Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study. Critical Care, 18(6): 596